Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,436
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
for
Solid Tumor
Location: Seattle WA, Westwood KS, Iowa City IA, Houston TX,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT05584670
Phase1, Phase2, Recruiting
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
for
Prostate Cancer
Location: Seattle WA, San Francisco CA, Milwaukee WI, St Louis MO,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT06613100
Phase1, Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 0+
Code: NCT04195633
Phase2, Recruiting
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Seattle WA, Sacramento CA, San Francisco CA,
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Seattle WA, Phoenix AZ, Rochester MN, Chicago IL,
Sponsor: Chordia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05732103
Phase1, Phase2, Recruiting
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Seattle WA, St Louis MO
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06179303
Phase2, Recruiting
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
for
Castration Resistant Metastatic Prostate Cancer
Location: Seattle WA, San Diego CA, Omaha NE, Minneapolis MN,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18 - 70+
Code: NCT04363164
Phase2, Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Seattle WA, Salt Lake City UT, Colorado Springs CO,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05413421
Phase1, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Seattle WA, Las Vegas NV, Duarte CA, Orange CA,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase3, Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
for
Myelodysplastic/Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT07228624
Phase2, Recruiting
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 3+
Code: NCT05866302
Recruiting
Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological Malignancies
for
Hematopoietic and Lymphatic System Neoplasm
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT04829136
Recruiting
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Englewood CO,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: Seattle WA, Salt Lake City UT, Phoenix AZ, Rochester MN,
Sponsor: 858 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06395519
Phase1, Phase2, Recruiting
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia